Marja-Riitta Taskinen

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Geographic Areas

Finland

Concepts & Ideas

Risk Factors

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Cefalù Angelo B; Noto Davide; Arpi Maria Luisa; Yin Fen; Spina Rossella; Hilden Hannele; Barbagallo Carlo M; Carroccio Antonio; Tarugi Patrizia; Squatrito Sebastiano; Vigneri Riccardo; Taskinen Marja-Riitta; Péterfy Miklós; Averna Maurizio R
Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia.
Di Marzo Vincenzo; Verrijken An; Hakkarainen Antti; Petrosino Stefania; Mertens Ilse; Lundbom Nina; Piscitelli Fabiana; Westerbacka Jukka; Soro-Paavonen Aino; Matias Isabel; Van Gaal Luc; Taskinen Marja-Riitta
Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects.
Lundbom Jesper; Heikkinen Sami; Fielding Barbara; Hakkarainen Antti; Taskinen Marja-Riitta; Lundbom Nina
PRESS echo time behavior of triglyceride resonances at 1.5T: detecting omega-3 fatty acids in adipose tissue in vivo.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Marja-Riitta Taskinen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Cefalù Angelo B; Noto Davide; Arpi Maria Luisa; Yin Fen; Spina Rossella; Hilden Hannele; Barbagallo Carlo M; Carroccio Antonio; Tarugi Patrizia; Squatrito Sebastiano; Vigneri Riccardo; Taskinen Marja-Riitta; Péterfy Miklós; Averna Maurizio R
Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia.
The Journal of clinical endocrinology and metabolism 2009;94(11):4584-90.
2009: Di Marzo Vincenzo; Verrijken An; Hakkarainen Antti; Petrosino Stefania; Mertens Ilse; Lundbom Nina; Piscitelli Fabiana; Westerbacka Jukka; Soro-Paavonen Aino; Matias Isabel; Van Gaal Luc; Taskinen Marja-Riitta
Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects.
European journal of endocrinology / European Federation of Endocrine Societies 2009;161(5):715-22.
2009: Lundbom Jesper; Heikkinen Sami; Fielding Barbara; Hakkarainen Antti; Taskinen Marja-Riitta; Lundbom Nina
PRESS echo time behavior of triglyceride resonances at 1.5T: detecting omega-3 fatty acids in adipose tissue in vivo.
Journal of magnetic resonance (San Diego, Calif. : 1997) 2009;201(1):39-47.
2009: Meex Steven J R; Weissglas-Volkov Daphna; van der Kallen Carla J H; Thuerauf Donna J; van Greevenbroek Marleen M J; Schalkwijk Casper G; Stehouwer Coen D A; Feskens Edith J M; Heldens Lonneke; Ayoubi Torik A; Hofker Marten H; Wouters Bradly G; Vlietinck Robert; Sinsheimer Janet S; Taskinen Marja-Riitta; Kuusisto Johanna; Laakso Markku; de Bruin Tjerk W A; Pajukanta Päivi; Glembotski Christopher C
The ATF6-Met[67]Val substitution is associated with increased plasma cholesterol levels.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(9):1322-7.
2009: Hiukka Anne; Ståhlman Marcus; Pettersson Camilla; Levin Malin; Adiels Martin; Teneberg Susanne; Leinonen Eeva S; Hultén Lillemor Mattsson; Wiklund Olov; Oresic Matej; Olofsson Sven-Olof; Taskinen Marja-Riitta; Ekroos Kim; Borén Jan
ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan.
Diabetes 2009;58(9):2018-26.
2009: Perttilä Julia; Merikanto Krista; Naukkarinen Jussi; Surakka Ida; Martin Nicolas W; Tanhuanpää Kimmo; Grimard Vinciane; Taskinen Marja-Riitta; Thiele Christoph; Salomaa Veikko; Jula Antti; Perola Markus; Virtanen Ismo; Peltonen Leena; Olkkonen Vesa M
OSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolism.
Journal of molecular medicine (Berlin, Germany) 2009;87(8):825-35.
2009: Pietiläinen Kirsi H; Söderlund Sanni; Rissanen Aila; Nakanishi Shuhei; Jauhiainen Matti; Taskinen Marja-Riitta; Kaprio Jaakko
HDL subspecies in young adult twins: heritability and impact of overweight.
Obesity (Silver Spring, Md.) 2009;17(6):1208-14.
2009: Taskinen Marja-Riitta; Sullivan David R; Ehnholm Christian; Whiting Malcolm; Zannino Diana; Simes R John; Keech Anthony C; Barter Philip J;
Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(6):950-5.
2009: Bunck Mathijs C; Diamant Michaela; Cornér Anja; Eliasson Bjorn; Malloy Jaret L; Shaginian Rimma M; Deng Wei; Kendall David M; Taskinen Marja-Riitta; Smith Ulf; Yki-Järvinen Hannele; Heine Robert J
One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial.
Diabetes care 2009;32(5):762-8.
2009: Kotronen A; Velagapudi V R; Yetukuri L; Westerbacka J; Bergholm R; Ekroos K; Makkonen J; Taskinen M-R; Oresic M; Yki-Järvinen H
Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations.
Diabetologia 2009;52(4):684-90.
2009: Taskinen Marja-Riitta
ADAGIO-Lipids gives promises but faces the setbacks.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(3):339-40.
2009: Scott Russell; O'Brien Richard; Fulcher Greg; Pardy Chris; D'Emden Michael; Tse Dana; Taskinen Marja-Riitta; Ehnholm Christian; Keech Anthony;
Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
Diabetes care 2009;32(3):493-8.
2009: Nakanishi Shuhei; Vikstedt Riikka; Söderlund Sanni; Lee-Rueckert Miriam; Hiukka Anne; Ehnholm Christian; Muilu Mikko; Metso Jari; Naukkarinen Jussi; Palotie Leena; Kovanen Petri T; Jauhiainen Matti; Taskinen Marja-Riitta
Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity.
Journal of lipid research 2009;50(2):183-92.
2008: Kumpula Linda S; Kumpula Jussi M; Taskinen Marja-Riitta; Jauhiainen Matti; Kaski Kimmo; Ala-Korpela Mika
Reconsideration of hydrophobic lipid distributions in lipoprotein particles.
Chemistry and physics of lipids 2008;155(1):57-62.
2008: Lee Jenny C; Weissglas-Volkov Daphna; Kyttälä Mira; Dastani Zari; Cantor Rita M; Sobel Eric M; Plaisier Christopher L; Engert James C; van Greevenbroek Marleen M J; Kane John P; Malloy Mary J; Pullinger Clive R; Huertas-Vazquez Adriana; Aguilar-Salinas Carlos A; Tusie-Luna Teresa; de Bruin Tjerk W A; Aouizerat Bradley E; van der Kallen Carla C J; Croce Carlo M; Aqeilan Rami I; Marcil Michel; Viikari Jorma S A; Lehtimäki Terho; Raitakari Olli T; Kuusisto Johanna; Laakso Markku; Taskinen Marja-Riitta; Genest Jacques; Pajukanta Päivi
WW-domain-containing oxidoreductase is associated with low plasma HDL-C levels.
American journal of human genetics 2008;83(2):180-92.
2008: Adiels Martin; Olofsson Sven-Olof; Taskinen Marja-Riitta; Borén Jan
Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(7):1225-36.
2008: Moren Xenia; Deakin Sara; Liu Ming-Lin; Taskinen Marja-Riitta; James Richard W
HDL subfraction distribution of paraoxonase-1 and its relevance to enzyme activity and resistance to oxidative stress.
Journal of lipid research 2008;49(6):1246-53.
2008: Granér Marit; Kahri Juhani; Varpula Marjut; Salonen Riitta M; Nyyssönen Kristiina; Jauhiainen Matti; Nieminen Markku S; Syvänne Mikko; Taskinen Marja-Riitta
Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2008;18(4):271-7.
2008: Auro K; Kristiansson K; Zethelius B; Berne C; Lannfelt L; Taskinen M-R; Jauhiainen M; Perola M; Peltonen L; Syvänen A-C
USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up study.
Diabetologia 2008;51(3):464-72.
2008: Adiels Martin; Taskinen Marja-Riitta; Borén Jan
Fatty liver, insulin resistance, and dyslipidemia.
Current diabetes reports 2008;8(1):60-4.
2008: Kathiresan Sekar; Melander Olle; Guiducci Candace; Surti Aarti; Burtt Noël P; Rieder Mark J; Cooper Gregory M; Roos Charlotta; Voight Benjamin F; Havulinna Aki S; Wahlstrand Björn; Hedner Thomas; Corella Dolores; Tai E Shyong; Ordovas Jose M; Berglund Göran; Vartiainen Erkki; Jousilahti Pekka; Hedblad Bo; Taskinen Marja-Riitta; Newton-Cheh Christopher; Salomaa Veikko; Peltonen Leena; Groop Leif; Altshuler David M; Orho-Melander Marju
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.
Nature genetics 2008;40(2):189-97.
2008: Tolonen N; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Saraheimo M; Heikkilä O; Pettersson-Fernholm K; Taskinen M-R; Groop P-H;
Relationship between lipid profiles and kidney function in patients with type 1 diabetes.
Diabetologia 2008;51(1):12-20.
2008: Huertas-Vazquez A; Plaisier C; Weissglas-Volkov D; Sinsheimer J; Canizales-Quinteros S; Cruz-Bautista I; Nikkola E; Herrera-Hernandez M; Davila-Cervantes A; Tusie-Luna T; Taskinen M-R; Aguilar-Salinas C; Pajukanta P
TCF7L2 is associated with high serum triacylglycerol and differentially expressed in adipose tissue in families with familial combined hyperlipidaemia.
Diabetologia 2008;51(1):62-9.
2007: Keech A C; Mitchell P; Summanen P A; O'Day J; Davis T M E; Moffitt M S; Taskinen M-R; Simes R J; Tse D; Williamson E; Merrifield A; Laatikainen L T; d'Emden M C; Crimet D C; O'Connell R L; Colman P G;
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.
Lancet 2007;370(9600):1687-97.
2007: Taskinen Marja-Riitta
Is metabolic syndrome the main threat to human health in the twenty-first century?
Arteriosclerosis, thrombosis, and vascular biology 2007;27(11):2275.
2007: Adiels M; Westerbacka J; Soro-Paavonen A; Häkkinen A M; Vehkavaara S; Caslake M J; Packard C; Olofsson S O; Yki-Järvinen H; Taskinen M R; Borén J
Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance.
Diabetologia 2007;50(11):2356-65.
2007: Suna Teemu; Salminen Aino; Soininen Pasi; Laatikainen Reino; Ingman Petri; Mäkelä Sanna; Savolainen Markku J; Hannuksela Minna L; Jauhiainen Matti; Taskinen Marja-Riitta; Kaski Kimmo; Ala-Korpela Mika
1H NMR metabonomics of plasma lipoprotein subclasses: elucidation of metabolic clustering by self-organising maps.
NMR in biomedicine 2007;20(7):658-72.
2007: Hiukka A; Leinonen E; Jauhiainen M; Sundvall J; Ehnholm C; Keech A C; Taskinen M R
Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus.
Diabetologia 2007;50(10):2067-75.
2007: Groop Per-Henrik; Thomas Merlin C; Rosengård-Bärlund Milla; Mills Vashti; Rönnback Mats; Thomas Stephen; Forsblom Carol; Taskinen Maria-Rita; Viberti Giancarlo
HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes.
Diabetes care 2007;30(10):2706-7.
2007: Matikainen Niina; Mänttäri Sakari; Westerbacka Jukka; Vehkavaara Satu; Lundbom Nina; Yki-Järvinen Hannele; Taskinen Marja-Riitta
Postprandial lipemia associates with liver fat content.
The Journal of clinical endocrinology and metabolism 2007;92(8):3052-9.
2007: Kahri Juhani; Fruchart-Najib Jamila; Matikainen Niina; Fruchart Jean-Charles; Vakkilainen Juha; Taskinen Marja-Riitta
The increase of apolipoprotein A-V during postprandial lipemia parallels the response of triglyceride-rich lipoproteins in type 2 diabetes: no relationship between apoA-V and postheparin plasma lipolytic activity.
Diabetes care 2007;30(8):2083-5.
2007: Sysi-Aho Marko; Vehtari Aki; Velagapudi Vidya R; Westerbacka Jukka; Yetukuri Laxman; Bergholm Robert; Taskinen Marja-Riitta; Yki-Järvinen Hannele; Oresic Matej
Exploring the lipoprotein composition using Bayesian regression on serum lipidomic profiles.
Bioinformatics (Oxford, England) 2007;23(13):i519-28.
2007: Soro-Paavonen Aino; Naukkarinen Jussi; Lee-Rueckert Miriam; Watanabe Hiroshi; Rantala Elina; Soderlund Sanni; Hiukka Anne; Kovanen Petri T; Jauhiainen Matti; Peltonen Leena; Taskinen Marja-Riitta
Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDL.
Journal of lipid research 2007;48(6):1409-16.
2007: Taskinen Marja-Riitta
The role of PPAR-alpha agonists in the prevention of CVD in diabetes.
Current diabetes reports 2007;7(2):83-5.
2007: Ala-Korpela Mika; Lankinen Niko; Salminen Aino; Suna Teemu; Soininen Pasi; Laatikainen Reino; Ingman Petri; Jauhiainen Matti; Taskinen Marja-Riitta; Héberger Károly; Kaski Kimmo
The inherent accuracy of 1H NMR spectroscopy to quantify plasma lipoproteins is subclass dependent.
Atherosclerosis 2007;190(2):352-8.
2007: Granér Marit; Syvänne Mikko; Kahri Juhani; Nieminen Markku S; Taskinen Marja-Riitta
Insulin resistance as predictor of the angiographic severity and extent of coronary artery disease.
Annals of medicine 2007;39(2):137-44.
2007: Fredriksson Jenny; Anevski Dragi; Almgren Peter; Sjögren Marketa; Lyssenko Valeriya; Carlson Joyce; Isomaa Bo; Taskinen Marja-Riitta; Groop Leif; Orho-Melander Marju;
Variation in GYS1 interacts with exercise and gender to predict cardiovascular mortality.
PloS one 2007;2(3):e285.
2006: Taskinen Marja-Riitta
Should we dismiss fibrates for the treatment of diabetic dyslipidaemia?
Nutrition, metabolism, and cardiovascular diseases : NMCD 2006;16(8):509-12.
2006: Granér M; Kahri J; Nakano T; Sarna S J; Nieminen M S; Syvänne M; Taskinen M R
Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease.
European journal of clinical investigation 2006;36(11):764-70.
2006: Keech Anthony; Simes John; Barter Philip; Best James; Scott Russell; Taskinen Marja-Riitta;
Correction to the FIELD study report.
Lancet 2006;368(9545):1415.
2006: Hero Matti; Ankarberg-Lindgren Carina; Taskinen Marja-Riitta; Dunkel Leo
Blockade of oestrogen biosynthesis in peripubertal boys: effects on lipid metabolism, insulin sensitivity, and body composition.
European journal of endocrinology / European Federation of Endocrine Societies 2006;155(3):453-60.
2006: Matikainen N; Mänttäri S; Schweizer A; Ulvestad A; Mills D; Dunning B E; Foley J E; Taskinen M-R
Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes.
Diabetologia 2006;49(9):2049-57.
2006: Weissglas-Volkov Daphna; Huertas-Vazquez Adriana; Suviolahti Elina; Lee Jenny; Plaisier Christopher; Canizales-Quinteros Samuel; Tusie-Luna Teresa; Aguilar-Salinas Carlos; Taskinen Marja-Riitta; Pajukanta Päivi
Common hepatic nuclear factor-4alpha variants are associated with high serum lipid levels and the metabolic syndrome.
Diabetes 2006;55(7):1970-7.
2006: Granér Marit; James Richard W; Kahri Juhani; Nieminen Markku S; Syvänne Mikko; Taskinen Marja-Riitta
Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery disease.
Journal of the American College of Cardiology 2006;47(12):2429-35.
2006: Adiels Martin; Olofsson Sven-Olof; Taskinen Marja-Riitta; Borén Jan
Diabetic dyslipidaemia.
Current opinion in lipidology 2006;17(3):238-46.
2006: Watanabe Hiroshi; Söderlund Sanni; Soro-Paavonen Aino; Hiukka Anne; Leinonen Eeva; Alagona Corradina; Salonen Riitta; Tuomainen Tomi-Pekka; Ehnholm Christian; Jauhiainen Matti; Taskinen Marja-Riitta
Decreased high-density lipoprotein (HDL) particle size, prebeta-, and large HDL subspecies concentration in Finnish low-HDL families: relationship with intima-media thickness.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(4):897-902.
2006: Adiels M; Taskinen M-R; Packard C; Caslake M J; Soro-Paavonen A; Westerbacka J; Vehkavaara S; Häkkinen A; Olofsson S-O; Yki-Järvinen H; Borén J
Overproduction of large VLDL particles is driven by increased liver fat content in man.
Diabetologia 2006;49(4):755-65.
2006: Granér Marit; Varpula Marjut; Kahri Juhani; Salonen Riitta M; Nyyssönen Kristiina; Nieminen Markku S; Taskinen Marja-Riitta; Syvänne Mikko
Association of carotid intima-media thickness with angiographic severity and extent of coronary artery disease.
The American journal of cardiology 2006;97(5):624-9.
2006: Al Majali K; Cooper M B; Staels B; Luc G; Taskinen M-R; Betteridge D J
The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients.
Diabetologia 2006;49(3):527-37.
2006: Thomas Merlin C; Rosengård-Bärlund Milla; Mills Vashti; Rönnback Mats; Thomas Stephen; Forsblom Carol; Cooper Mark E; Taskinen Marja-Riitta; Viberti Giancarlo; Groop Per-Henrik
Serum lipids and the progression of nephropathy in type 1 diabetes.
Diabetes care 2006;29(2):317-22.
2006: Suviolahti Elina; Reue Karen; Cantor Rita M; Phan Jack; Gentile Massimiliano; Naukkarinen Jussi; Soro-Paavonen Aino; Oksanen Laura; Kaprio Jaakko; Rissanen Aila; Salomaa Veikko; Kontula Kimmo; Taskinen Marja-Riitta; Pajukanta Päivi; Peltonen Leena
Cross-species analyses implicate Lipin 1 involvement in human glucose metabolism.
Human molecular genetics 2006;15(3):377-86.
2006: Kahri Juhani; Soro-Paavonen Aino; Ehnholm Christian; Taskinen Marja-Riitta
ApoE polymorphism is associated with C-reactive protein in low-HDL family members and in normolipidemic subjects.
Mediators of inflammation 2006;2006(3):12587.
2006: Soro-Paavonen Aino; Westerbacka Jukka; Ehnholm Christian; Taskinen Marja-Riitta
Metabolic syndrome aggravates the increased endothelial activation and low-grade inflammation in subjects with familial low HDL.
Annals of medicine 2006;38(3):229-38.
2005: Sammalisto S; Hiekkalinna T; Suviolahti E; Sood K; Metzidis A; Pajukanta P; Lilja H E; Soro-Paavonen A; Taskinen M-R; Tuomi T; Almgren P; Orho-Melander M; Groop L; Peltonen L; Perola M
A male-specific quantitative trait locus on 1p21 controlling human stature.
Journal of medical genetics 2005;42(12):932-9.
2005: Keech A; Simes R J; Barter P; Best J; Scott R; Taskinen M R; Forder P; Pillai A; Davis T; Glasziou P; Drury P; Kesäniemi Y A; Sullivan D; Hunt D; Colman P; d'Emden M; Whiting M; Ehnholm C; Laakso M;
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
Lancet 2005;366(9500):1849-61.
2005: Naukkarinen Jussi; Gentile Massimiliano; Soro-Paavonen Aino; Saarela Janna; Koistinen Heikki A; Pajukanta Päivi; Taskinen Marja-Riitta; Peltonen Leena
USF1 and dyslipidemias: converging evidence for a functional intronic variant.
Human molecular genetics 2005;14(17):2595-605.
2005: Thorn Lena M; Forsblom Carol; Fagerudd Johan; Thomas Merlin C; Pettersson-Fernholm Kim; Saraheimo Markku; Wadén Johan; Rönnback Mats; Rosengård-Bärlund Milla; Björkesten Clas-Göran Af; Taskinen Marja-Riitta; Groop Per-Henrik;
Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study).
Diabetes care 2005;28(8):2019-24.
2005: Westerbacka J; Leinonen E; Salonen J T; Salonen R; Hiukka A; Yki-Järvinen H; Taskinen M-R
Increased augmentation of central blood pressure is associated with increases in carotid intima-media thickness in type 2 diabetic patients.
Diabetologia 2005;48(8):1654-62.
2005: Adiels Martin; Borén Jan; Caslake Muriel J; Stewart Philip; Soro Aino; Westerbacka Jukka; Wennberg Bernt; Olofsson Sven-Olof; Packard Chris; Taskinen Marja-Riitta
Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(8):1697-703.
2005: Söderlund Sanni; Soro-Paavonen Aino; Ehnholm Christian; Jauhiainen Matti; Taskinen Marja-Riitta
Hypertriglyceridemia is associated with prebeta-HDL concentrations in subjects with familial low HDL.
Journal of lipid research 2005;46(8):1643-51.
2005: Johanson E H; Jansson P-A; Gustafson B; Sandqvist M; Taskinen M-R; Smith U; Axelsen M
No acute effect of nateglinide on postprandial lipid and lipoprotein responses in subjects at risk for type 2 diabetes.
Diabetes/metabolism research and reviews 2005;21(4):376-81.
2005: Hiukka Anne; Fruchart-Najib Jamila; Leinonen Eeva; Hilden Hannele; Fruchart Jean-Charles; Taskinen Marja-Riitta
Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes.
Diabetologia 2005;48(6):1207-15.
2005: Taskinen M-R
Type 2 diabetes as a lipid disorder.
Current molecular medicine 2005;5(3):297-308.
2005: Brekke Hilde K; Lenner Ragnhild A; Taskinen Marja-Riitta; Månsson Jan-Eric; Funahashi Tohru; Matsuzawa Yuji; Jansson Per-Anders
Lifestyle modification improves risk factors in type 2 diabetes relatives.
Diabetes research and clinical practice 2005;68(1):18-28.
2005: Ansquer Jean-Claude; Foucher Christelle; Rattier Stephanie; Taskinen Marja-Riitta; Steiner George;
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(3):485-93.
2005: Nowak Maxime; Helleboid-Chapman Audrey; Jakel Heidelinde; Martin Geneviève; Duran-Sandoval Daniel; Staels Bart; Rubin Edward M; Pennacchio Len A; Taskinen Marja-Riitta; Fruchart-Najib Jamila; Fruchart Jean-Charles
Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor.
Molecular and cellular biology 2005;25(4):1537-48.
2005: Lyssenko Valeriya; Almgren Peter; Anevski Dragi; Perfekt Roland; Lahti Kaj; Nissén Michael; Isomaa Bo; Forsen Björn; Homström Nils; Saloranta Carola; Taskinen Marja-Riitta; Groop Leif; Tuomi Tiinamaija;
Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes.
Diabetes 2005;54(1):166-74.
2005: Adiels Martin; Packard Chris; Caslake Muriel J; Stewart Philip; Soro Aino; Westerbacka Jukka; Wennberg Bernt; Olofsson Sven-Olof; Taskinen Marja-Riitta; Borén Jan
A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions.
Journal of lipid research 2005;46(1):58-67.
2005: Scott R; Best J; Forder P; Taskinen M-R; Simes J; Barter P; Keech A;
Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481].
Cardiovascular diabetology 2005;4():13.
2004: Jänis Minna T; Siggins Sarah; Tahvanainen Esa; Vikstedt Riikka; Silander Kaisa; Metso Jari; Aromaa Arpo; Taskinen Marja-Riitta; Olkkonen Vesa M; Jauhiainen Matti; Ehnholm Christian
Active and low-active forms of serum phospholipid transfer protein in a normal Finnish population sample.
Journal of lipid research 2004;45(12):2303-9.
2004: Elrayess Mohamed A; Webb Karen E; Bellingan Geoff J; Whittall Ros A; Kabir Jahangir; Hawe Emma; Syvänne Mikko; Taskinen Marja-Riitta; Frick M Heikki; Nieminen Markku S; Kesäniemi Y Antero; Pasternack Amos; Miller George J; Humphries Steve E
R643G polymorphism in PECAM-1 influences transendothelial migration of monocytes and is associated with progression of CHD and CHD events.
Atherosclerosis 2004;177(1):127-35.
2004: Lilja Heidi E; Suviolahti Elina; Soro-Paavonen Aino; Hiekkalinna Tero; Day Aaron; Lange Kenneth; Sobel Eric; Taskinen Marja-Riitta; Peltonen Leena; Perola Markus; Pajukanta Päivi
Locus for quantitative HDL-cholesterol on chromosome 10q in Finnish families with dyslipidemia.
Journal of lipid research 2004;45(10):1876-84.
2004: Leinonen E S; Hiukka A; Hurt-Camejo E; Wiklund O; Sarna S S; Mattson Hultén L; Westerbacka J; Salonen R M; Salonen J T; Taskinen M-R
Low-grade inflammation, endothelial activation and carotid intima-media thickness in type 2 diabetes.
Journal of internal medicine 2004;256(2):119-27.
2004: Liu Ming-Lin; Ylitalo Kati; Salonen Riitta; Salonen Jukka T; Taskinen Marja-Riitta
Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia families.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(8):1492-7.
2004: Witte D R; Taskinen M R; Perttunen-Nio H; Van Tol A; Livingstone S; Colhoun H M
Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresis.
Journal of lipid research 2004;45(6):1069-76.
2004: Ambring Anneli; Friberg Peter; Axelsen Mette; Laffrenzen Magdalena; Taskinen Marja-Riitta; Basu Samar; Johansson Mats
Effects of a Mediterranean-inspired diet on blood lipids, vascular function and oxidative stress in healthy subjects.
Clinical science (London, England : 1979) 2004;106(5):519-25.
2004: Liu M L; James R W; Ylitalo K; Taskinen M R
Associations between HDL oxidation and paraoxonase-1 and paraoxonase-1 gene polymorphisms in families affected by familial combined hyperlipidemia.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2004;14(2):81-7.
2004: Tilly-Kiesi Marju; Schaefer Ernst J; Knudsen Petteri; Welty Francine K; Dolnikowski Gregory G; Taskinen Marja-Riitta; Lichtenstein Alice H
Lipoprotein metabolism in subjects with hepatic lipase deficiency.
Metabolism: clinical and experimental 2004;53(4):520-5.
2004: Pajukanta Päivi; Lilja Heidi E; Sinsheimer Janet S; Cantor Rita M; Lusis Aldons J; Gentile Massimiliano; Duan Xiaoqun Joyce; Soro-Paavonen Aino; Naukkarinen Jussi; Saarela Janna; Laakso Markku; Ehnholm Christian; Taskinen Marja-Riitta; Peltonen Leena
Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).
Nature genetics 2004;36(4):371-6.
2004: Talmud Philippa J; Martin Steve; Taskinen Marja-Riitta; Frick M Heikki; Nieminen Markku S; Kesäniemi Y Antero; Pasternack Amos; Humphries Steve E; Syvänne Mikko
APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study.
Journal of lipid research 2004;45(4):750-6.
2004: Syvänne Mikko; Whittall Roslyn A; Turpeinen Ursula; Nieminen Markku S; Frick M Heikki; Kesäniemi Y Antero; Pasternack Amos; Humphries Steve E; Taskinen Marja-Riitta
Serum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosis.
Atherosclerosis 2004;172(2):267-72.
2004: Johanson E H; Jansson P-A; Gustafson B; Lönn L; Smith U; Taskinen M-R; Axelsen M
Early alterations in the postprandial VLDL1 apoB-100 and apoB-48 metabolism in men with strong heredity for type 2 diabetes.
Journal of internal medicine 2004;255(2):273-9.
2003: Johanson Else H; Jansson Per-Anders; Lönn Lars; Matsuzawa Yuji; Funahashi Tohru; Taskinen Marja-Riitta; Smith Ulf; Axelsen Mette
Fat distribution, lipid accumulation in the liver, and exercise capacity do not explain the insulin resistance in healthy males with a family history for type 2 diabetes.
The Journal of clinical endocrinology and metabolism 2003;88(9):4232-8.
2003: Jansson Per-Anders; Pellmé Fredrik; Hammarstedt Ann; Sandqvist Madeléne; Brekke Hilde; Caidahl Kenneth; Forsberg Margeta; Volkmann Reinhard; Carvalho Eugénia; Funahashi Tohru; Matsuzawa Yuji; Wiklund Olle; Yang Xiaolin; Taskinen Marja-Riita; Smith Ulf
A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(11):1434-40.
2003: Soro Aino; Jauhiainen Matti; Ehnholm Christian; Taskinen Marja-Riitta
Determinants of low HDL levels in familial combined hyperlipidemia.
Journal of lipid research 2003;44(8):1536-44.
2003: Taskinen Marja Riitta
LDL-cholesterol, HDL-cholesterol or triglycerides--which is the culprit?
Diabetes research and clinical practice 2003;61 Suppl 1():S19-26.
2003: Alagona C; Soro A; Westerbacka J; Ylitalo K; Salonen J T; Salonen R; Yki-Järvinen H; Taskinen M-R
Low HDL cholesterol concentration is associated with increased intima-media thickness independent of arterial stiffness in healthy subjects from families with low HDL cholesterol.
European journal of clinical investigation 2003;33(6):457-63.
2003: Taskinen M-R
Diabetic dyslipidaemia: from basic research to clinical practice.
Diabetologia 2003;46(6):733-49.
2003: Elrayess Mohamed A; Webb Karen E; Flavell David M; Syvänne Mikko; Taskinen Marja-Riitta; Frick M Heikki; Nieminen Markku S; Kesäniemi Y Antero; Pasternack Amos; Jukema J Wouter; Kastelein John J P; Zwinderman Aeilko H; Humphries Steve E
A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studies.
Atherosclerosis 2003;168(1):131-8.
2003: Pellmé F; Smith U; Funahashi T; Matsuzawa Y; Brekke H; Wiklund O; Taskinen M-R; Jansson P-A
Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.
Diabetes 2003;52(5):1182-6.
2003: Talmud Philippa J; Martin Steve; Steiner George; Flavell David M; Whitehouse David B; Nagl Sylvia; Jackson Richard; Taskinen Marja-Riitta; Frick M Heikki; Nieminen Markku S; Kesäniemi Y Antero; Pasternack Amos; Humphries Steve E; Syvänne Mikko;
Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(4):644-9.
2003: Vakkilainen Juha; Steiner George; Ansquer Jean-Claude; Aubin Francois; Rattier Stephanie; Foucher Christelle; Hamsten Anders; Taskinen Marja-Riitta;
Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS).
Circulation 2003;107(13):1733-7.
2003: Pajukanta Päivi; Allayee Hooman; Krass Kelly L; Kuraishy Ali; Soro Aino; Lilja Heidi E; Mar Rebecca; Taskinen Marja-Riitta; Nuotio Ilpo; Laakso Markku; Rotter Jerome I; de Bruin Tjerk W A; Cantor Rita M; Lusis Aldons J; Peltonen Leena
Combined analysis of genome scans of dutch and finnish families reveals a susceptibility locus for high-density lipoprotein cholesterol on chromosome 16q.
American journal of human genetics 2003;72(4):903-17.
2003: Leinonen Eeva; Hurt-Camejo Eva; Wiklund Olov; Hultén Lillemor Mattson; Hiukka Anne; Taskinen Marja-Riitta
Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes.
Atherosclerosis 2003;166(2):387-94.
2002: Alagona Corradina; Soro Aino; Ylitalo Kati; Salonen Riitta; Salonen Jukka T; Taskinen Marja-Riitta
A low high density lipoprotein (HDL) level is associated with carotid artery intima-media thickness in asymptomatic members of low HDL families.
Atherosclerosis 2002;165(2):309-16.
2002: Vakkilainen Juha; Mero Niina; Schweizer Anja; Foley James E; Taskinen Marja-Riitta
Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes.
Diabetes/metabolism research and reviews 2002;18(6):484-90.
2002: Colhoun Helen M; Taskinen Marja-Riitta; Otvos James D; Van Den Berg Paul; O'Connor John; Van Tol Arie
Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes.
Diabetes 2002;51(11):3300-5.
2002: Bergholm Robert; Leirisalo-Repo Marjatta; Vehkavaara Satu; Mäkimattila Sari; Taskinen Marja-Riitta; Yki-Järvinen Hannele
Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(10):1637-41.
2002: Leinonen Eeva S; Salonen Jukka T; Salonen Riitta M; Koistinen Riitta A; Leinonen Pekka J; Sarna Seppo S; Taskinen Marja-Riitta
Reduced IGFBP-1 is associated with thickening of the carotid wall in type 2 diabetes.
Diabetes care 2002;25(10):1807-12.
2002: Vakkilainen Juha; Pajukanta Päivi; Cantor Rita M; Nuotio Ilpo O; Lahdenperä Sanni; Ylitalo Kati; Pihlajamäki Jussi; Kovanen Petri T; Laakso Markku; Viikari Jorma S A; Peltonen Leena; Taskinen Marja-Riitta
Genetic influences contributing to LDL particle size in familial combined hyperlipidaemia.
European journal of human genetics : EJHG 2002;10(9):547-52.
2002: Lilja Heidi E; Soro Aino; Ylitalo Kati; Nuotio Ilpo; Viikari Jorma S A; Salomaa Veikko; Vartiainen Erkki; Taskinen Marja-Riitta; Peltonen Leena; Pajukanta Päivi
A candidate gene study in low HDL-cholesterol families provides evidence for the involvement of the APOA2 gene and the APOA1C3A4 gene cluster.
Atherosclerosis 2002;164(1):103-11.
2002: Colhoun Helen M; Otvos James D; Rubens Mike B; Taskinen M R; Underwood S Richard; Fuller John H
Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.
Diabetes 2002;51(6):1949-56.
2002: Mäkimattila S; Ylitalo K; Schlenzka A; Taskinen M-R; Summanen P; Syvänne M; Yki-Järvinen H
Family histories of Type II diabetes and hypertension predict intima-media thickness in patients with Type I diabetes.
Diabetologia 2002;45(5):711-8.
2002: Taskinen Marja-Riitta
Diabetic dyslipidemia.
Atherosclerosis. Supplements 2002;3(1):47-51.
2002: Liu Ming-Lin; Ylitalo Kati; Nuotio Ilpo; Salonen Riitta; Salonen Jukka T; Taskinen Marja-Riitta
Association between carotid intima-media thickness and low-density lipoprotein size and susceptibility of low-density lipoprotein to oxidation in asymptomatic members of familial combined hyperlipidemia families.
Stroke; a journal of cerebral circulation 2002;33(5):1255-60.
2002: Ylitalo Kati; Nuotio Ilpo; Viikari Jorma; Auwerx Johan; Vidal Hubert; Taskinen Marja-Riitta
C3, hormone-sensitive lipase, and peroxisome proliferator-activated receptor gamma expression in adipose tissue of familial combined hyperlipidemia patients.
Metabolism: clinical and experimental 2002;51(5):664-70.
2002: Ylitalo Kati; Syvänne Mikko; Salonen Riitta; Nuotio Ilpo; Taskinen Marja-Riitta; Salonen Jukka T
Carotid artery intima-media thickness in Finnish families with familial combined hyperlipidemia.
Atherosclerosis 2002;162(1):171-8.
2002: Soro Aino; Pajukanta Päivi; Lilja Heidi E; Ylitalo Kati; Hiekkalinna Tero; Perola Markus; Cantor Rita M; Viikari Jorma S A; Taskinen Marja-Riitta; Peltonen Leena
Genome scans provide evidence for low-HDL-C loci on chromosomes 8q23, 16q24.1-24.2, and 20q13.11 in Finnish families.
American journal of human genetics 2002;70(5):1333-40.
2002: Vakkilainen Juha; Jauhiainen Matti; Ylitalo Kati; Nuotio Ilpo O; Viikari Jorma S A; Ehnholm Christian; Taskinen Marja-Riitta
LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins.
Journal of lipid research 2002;43(4):598-603.
2002: Flavell David M; Jamshidi Yalda; Hawe Emma; Pineda Torra Inés; Taskinen Marja-Riitta; Frick M Heikki; Nieminen Markku S; Kesäniemi Y Antero; Pasternack Amos; Staels Bart; Miller George; Humphries Steve E; Talmud Philippa J; Syvänne Mikko
Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease.
Circulation 2002;105(12):1440-5.
2002: Vakkilainen Juha; Steiner George; Ansquer Jean-Claude; Perttunen-Nio Hëlina; Taskinen Marja-Riitta
Fenofibrate lowers plasma triglycerides and increases LDL particle diameter in subjects with type 2 diabetes.
Diabetes care 2002;25(3):627-8.
2002: Liu Ming-Lin; Ylitalo Kati; Vakkilainen Juha; Nuotio Ilpo; Valkonen Miia; Lahdenperä Sanni; Viikari Jorma; Taskinen Marja-Riitta
Susceptibility of LDL to oxidation in vitro and antioxidant capacity in familial combined hyperlipidemia: comparison of patients with different lipid phenotypes.
Annals of medicine 2002;34(1):48-54.
2001: Chaturvedi N; Fuller J H; Taskinen M R;
Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes.
Diabetes care 2001;24(12):2071-7.
2001: Isomaa B; Henricsson M; Almgren P; Tuomi T; Taskinen M R; Groop L
The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes.
Diabetologia 2001;44(9):1148-54.
2001: Lehtovirta M; Forsén B; Gullström M; Häggblom M; Eriksson J G; Taskinen M R; Groop L
Metabolic effects of metformin in patients with impaired glucose tolerance.
Diabetic medicine : a journal of the British Diabetic Association 2001;18(7):578-83.
2001: Karpe F; Taskinen M R; Nieminen M S; Frick M H; Kesäniemi Y A; Pasternack A; Hamsten A; Syvänne M
Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment.
Atherosclerosis 2001;157(1):181-7.
2001: Ylitalo K; Pajukanta P; Meri S; Cantor R M; Mero-Matikainen N; Vakkilainen J; Nuotio I; Taskinen M R
Serum C3 but not plasma acylation-stimulating protein is elevated in Finnish patients with familial combined hyperlipidemia.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(5):838-43.
2001: Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen M R; Yki-Järvinen H
Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
Thrombosis and haemostasis 2001;85(4):619-25.
2001: Isomaa B; Almgren P; Tuomi T; Forsén B; Lahti K; Nissén M; Taskinen M R; Groop L
Cardiovascular morbidity and mortality associated with the metabolic syndrome.
Diabetes care 2001;24(4):683-9.
2001: Pajunen P; Syvänne M; Castro G; Nieminen M S; Taskinen M R
Cholesterol efflux capacity in vitro predicts the severity and extent of coronary artery disease in patients with and without type 2 diabetes.
Scandinavian cardiovascular journal : SCJ 2001;35(2):96-100.
2001: Syvänne M; Pajunen P; Kahri J; Lahdenperä S; Ehnholm C; Nieminen M S; Taskinen M R
Determinants of the severity and extent of coronary artery disease in patients with type-2 diabetes and in nondiabetic subjects.
Coronary artery disease 2001;12(2):99-106.
2000: Ylitalo K; Large V; Pajukanta P; Reynisdottir S; Porkka K V; Vakkilainen J; Nuotio I; Taskinen M R; Arner P
Reduced hormone-sensitive lipase activity is not a major metabolic defect in Finnish FCHL families.
Atherosclerosis 2000;153(2):373-81.
2000: Vehkavaara S; Hakala-Ala-Pietilä T; Virkamäki A; Bergholm R; Ehnholm C; Hovatta O; Taskinen M R; Yki-Järvinen H
Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women.
Circulation 2000;102(22):2687-93.
2000: Pajunen P; Taskinen M R; Nieminen M S; Syvänne M
Angiographic severity and extent of coronary artery disease in patients with type 1 diabetes mellitus.
The American journal of cardiology 2000;86(10):1080-5.
2000: Taskinen M; Saarinen-Pihkala U M; Hovi L; Lipsanen-Nyman M
Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood.
Lancet 2000;356(9234):993-7.
2000: Klannemark M; Suurinkeroinen L; Orho-Melander M; Groop L; Taskinen M R
Interaction between the Asn291Ser variant of the LPL gene and insulin resistance on dyslipidaemia in high risk individuals for Type 2 diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 2000;17(8):599-605.
2000: Vakkilainen J; Mäkimattila S; Seppälä-Lindroos A; Vehkavaara S; Lahdenperä S; Groop P H; Taskinen M R; Yki-Järvinen H
Endothelial dysfunction in men with small LDL particles.
Circulation 2000;102(7):716-21.
2000: Svensson J; Bengtsson B A; Taskinen M R; Wiklund O; Johannsson G
A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2000;10(3):118-26.
2000: Tripathy D; Carlsson M; Almgren P; Isomaa B; Taskinen M R; Tuomi T; Groop L C
Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study.
Diabetes 2000;49(6):975-80.
2000: Li H; Isomaa B; Taskinen M R; Groop L; Tuomi T
Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes.
Diabetes care 2000;23(5):589-94.
2000: Axelsen M; Lönnroth P; Lenner R A; Taskinen M R; Smith U
Suppression of nocturnal fatty acid concentrations by bedtime carbohydrate supplement in type 2 diabetes: effects on insulin sensitivity, lipids, and glycemic control.
The American journal of clinical nutrition 2000;71(5):1108-14.
2000: Mero N; Malmström R; Steiner G; Taskinen M R; Syvänne M
Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease.
Atherosclerosis 2000;150(1):167-77.
2000: Hamsten A; Syvänne M; Silveira A; Luong L A; Nieminen M S; Humphries S; Frick M H; Taskinen M R
Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy.
Thrombosis and haemostasis 2000;83(3):397-403.
1999: Malmström R; Packard C J; Caslake M; Bedford D; Stewart P; Shepherd J; Taskinen M R
Effect of heparin-stimulated plasma lipolytic activity on VLDL APO B subclass metabolism in normal subjects.
Atherosclerosis 1999;146(2):381-90.
1999: Mero N; Suurinkeroinen L; Syvänne M; Knudsen P; Yki-Järvinen H; Taskinen M R
Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant.
Journal of lipid research 1999;40(9):1663-70.
1999: Bergholm R; Mäkimattila S; Valkonen M; Liu M L; Lahdenperä S; Taskinen M R; Sovijärvi A; Malmberg P; Yki-Järvinen H
Intense physical training decreases circulating antioxidants and endothelium-dependent vasodilatation in vivo.
Atherosclerosis 1999;145(2):341-9.
1999: Isomaa B; Almgren P; Henricsson M; Taskinen M R; Tuomi T; Groop L; Sarelin L
Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA).
Diabetes care 1999;22(8):1347-53.
1999: Axelsen M; Smith U; Eriksson J W; Taskinen M R; Jansson P A
Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes.
Annals of internal medicine 1999;131(1):27-31.
1999: Svensson J; Jansson J O; Ottosson M; Johannsson G; Taskinen M R; Wiklund O; Bengtsson B A
Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins, but not lipoprotein(a).
The Journal of clinical endocrinology and metabolism 1999;84(6):2028-33.
1999: Mäkimattila S; Liu M L; Vakkilainen J; Schlenzka A; Lahdenperä S; Syvänne M; Mäntysaari M; Summanen P; Bergholm R; Taskinen M R; Yki-Järvinen H
Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.
Diabetes care 1999;22(6):973-81.
1999: Liu M L; Bergholm R; Mäkimattila S; Lahdenperä S; Valkonen M; Hilden H; Yki-Järvinen H; Taskinen M R
A marathon run increases the susceptibility of LDL to oxidation in vitro and modifies plasma antioxidants.
The American journal of physiology 1999;276(6 Pt 1):E1083-91.
1999: Pajukanta P; Terwilliger J D; Perola M; Hiekkalinna T; Nuotio I; Ellonen P; Parkkonen M; Hartiala J; Ylitalo K; Pihlajamäki J; Porkka K; Laakso M; Viikari J; Ehnholm C; Taskinen M R; Peltonen L
Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels.
American journal of human genetics 1999;64(5):1453-63.
1999: Pitkänen O P; Nuutila P; Raitakari O T; Porkka K; Iida H; Nuotio I; Rönnemaa T; Viikari J; Taskinen M R; Ehnholm C; Knuuti J
Coronary flow reserve in young men with familial combined hyperlipidemia.
Circulation 1999;99(13):1678-84.
1999: Lehto M; Bitzén P O; Isomaa B; Wipemo C; Wessman Y; Forsblom C; Tuomi T; Taskinen M R; Groop L
Mutation in the HNF-4alpha gene affects insulin secretion and triglyceride metabolism.
Diabetes 1999;48(2):423-5.
1999: Tuomi T; Carlsson A; Li H; Isomaa B; Miettinen A; Nilsson A; Nissén M; Ehrnström B O; Forsén B; Snickars B; Lahti K; Forsblom C; Saloranta C; Taskinen M R; Groop L C
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
Diabetes 1999;48(1):150-7.
1999: Taskinen M R
Strategies for the management of diabetic dyslipidaemia.
Drugs 1999;58 Suppl 1():47-51; discussion 75-82.
1998: Mero N; Syvänne M; Taskinen M R
Postprandial lipid metabolism in diabetes.
Atherosclerosis 1998;141 Suppl 1():S53-5.
1998: Taskinen M R; Smith U
Lipid disorders in NIDDM: implications for treatment.
Journal of internal medicine 1998;244(5):361-70.
1998: Tahvanainen E; Pajukanta P; Porkka K; Nieminen S; Ikävalko L; Nuotio I; Taskinen M R; Peltonen L; Ehnholm C
Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemia.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(11):1810-7.
1998: Syvänne M; Nieminen M S; Frick M H; Kauma H; Majahalme S; Virtanen V; Kesäniemi Y A; Pasternack A; Ehnholm C; Taskinen M R
Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.
Circulation 1998;98(19):1993-9.
1998: Taskinen M R
Oestrogen replacement therapy and coronary heart disease.
Annals of medicine 1998;30(5):443-51.
1998: Taskinen M R
Broader metabolic control in diabetes management.
Diabetes/metabolism reviews 1998;14 Suppl 1():S39-43.
1998: Humphries S E; Luong L A; Talmud P J; Frick M H; Kesäniemi Y A; Pasternack A; Taskinen M R; Syvänne M
The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial.
Atherosclerosis 1998;139(1):49-56.
1998: Mero N; Van Tol A; Scheek L M; Van Gent T; Labeur C; Rosseneu M; Taskinen M R
Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities.
Journal of lipid research 1998;39(7):1493-502.
1998: Ilmonen M; Knudsen P; Taskinen M R; Tikkanen M J
Genetic variation in the amino-terminal part of apolipoprotein B: studies in hyperlipidemic patients.
Atherosclerosis 1998;138(2):367-74.
1998: Mero N; Syvänne M; Rosseneu M; Labeur C; Hilden H; Taskinen M R
Comparison of three fatty meals in healthy normolipidaemic men: high post-prandial retinyl ester response to soybean oil.
European journal of clinical investigation 1998;28(5):407-15.
1998: Malmström R; Packard C J; Caslake M; Bedford D; Stewart P; Yki-Järvinen H; Shepherd J; Taskinen M R
Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects.
Diabetes 1998;47(5):779-87.
1998: Pajukanta P; Nuotio I; Terwilliger J D; Porkka K V; Ylitalo K; Pihlajamäki J; Suomalainen A J; Syvänen A C; Lehtimäki T; Viikari J S; Laakso M; Taskinen M R; Ehnholm C; Peltonen L
Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23.
Nature genetics 1998;18(4):369-73.
1998: Tilly-Kiesi M; Lichtenstein A H; Rintarahko J; Taskinen M R
Postprandial responses of plasma lipids and lipoproteins in subjects with apoA-I(Lys107-->0).
Atherosclerosis 1998;137(1):37-47.
1998: Tahvanainen E; Syvanne M; Frick M H; Murtomaki-Repo S; Antikainen M; Kesaniemi Y A; Kauma H; Pasternak A; Taskinen M R; Ehnholm C
Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.
The Journal of clinical investigation 1998;101(5):956-60.
1998: Vakkilainen J; Porkka K V; Nuotio I; Pajukanta P; Suurinkeroinen L; Ylitalo K; Viikari J S; Ehnholm C; Taskinen M R
Glucose intolerance in familial combined hyperlipidaemia. EUFAM study group.
European journal of clinical investigation 1998;28(1):24-32.
1997: Yki-Järvinen H; Ryysy L; Kauppila M; Kujansuu E; Lahti J; Marjanen T; Niskanen L; Rajala S; Salo S; Seppälä P; Tulokas T; Viikari J; Taskinen M R
Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus.
The Journal of clinical endocrinology and metabolism 1997;82(12):4037-43.
1997: Knudsen P; Murtomäki S; Antikainen M; Ehnholm S; Lahdenperä S; Ehnholm C; Taskinen M R
The Asn-291-->Ser and Ser-477-->Stop mutations of the lipoprotein lipase gene and their significance for lipid metabolism in patients with hypertriglyceridaemia.
European journal of clinical investigation 1997;27(11):928-35.
1997: Mero N; Syvänne M; Eliasson B; Smith U; Taskinen M R
Postprandial elevation of ApoB-48-containing triglyceride-rich particles and retinyl esters in normolipemic males who smoke.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(10):2096-102.
1997: Frick M H; Syvänne M; Nieminen M S; Kauma H; Majahalme S; Virtanen V; Kesäniemi Y A; Pasternack A; Taskinen M R
Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group.
Circulation 1997;96(7):2137-43.
1997: Porkka K V; Nuotio I; Pajukanta P; Ehnholm C; Suurinkeroinen L; Syvänne M; Lehtimäki T; Lahdenkari A T; Lahdenperä S; Ylitalo K; Antikainen M; Perola M; Raitakari O T; Kovanen P; Viikari J S; Peltonen L; Taskinen M R
Phenotype expression in familial combined hyperlipidemia.
Atherosclerosis 1997;133(2):245-53.
1997: Pajunen P; Nieminen M S; Taskinen M R; Syvänne M
Quantitative comparison of angiographic characteristics of coronary artery disease in patients with noninsulin-dependent diabetes mellitus compared with matched nondiabetic control subjects.
The American journal of cardiology 1997;80(5):550-6.
1997: Malmström R; Packard C J; Watson T D; Rannikko S; Caslake M; Bedford D; Stewart P; Yki-Järvinen H; Shepherd J; Taskinen M R
Metabolic basis of hypotriglyceridemic effects of insulin in normal men.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(7):1454-64.
1997: Syvänne M; Talmud P J; Humphries S E; Fisher R M; Rosseneu M; Hilden H; Taskinen M R
Determinants of postprandial lipemia in men with coronary artery disease and low levels of HDL cholesterol.
Journal of lipid research 1997;38(7):1463-72.
1997: Syvänne M; Taskinen M R
Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus.
Lancet 1997;350 Suppl 1():SI20-3.
1997: Raitakari O T; Pitkänen O P; Lehtimäki T; Lahdenperä S; Iida H; Ylä-Herttuala S; Luoma J; Mattila K; Nikkari T; Taskinen M R; Viikari J S; Knuuti J
In vivo low density lipoprotein oxidation relates to coronary reactivity in young men.
Journal of the American College of Cardiology 1997;30(1):97-102.
1997: Taskinen M R
Triglyceride is the major atherogenic lipid in NIDDM.
Diabetes/metabolism reviews 1997;13(2):93-8.
1997: Eliasson B; Attvall S; Taskinen M R; Smith U
Smoking cessation improves insulin sensitivity in healthy middle-aged men.
European journal of clinical investigation 1997;27(5):450-6.
1997: Pajukanta P; Porkka K V; Antikainen M; Taskinen M R; Perola M; Murtomäki-Repo S; Ehnholm S; Nuotio I; Suurinkeroinen L; Lahdenkari A T; Syvänen A C; Viikari J S; Ehnholm C; Peltonen L
No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(5):841-50.
1997: Malmström R; Packard C J; Caslake M; Bedford D; Stewart P; Yki-Järvinen H; Shepherd J; Taskinen M R
Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM.
Diabetologia 1997;40(4):454-62.
1997: Ylitalo K; Porkka K V; Meri S; Nuotio I; Suurinkeroinen L; Vakkilainen J; Pajukanta P; Viikari J S; Peltonen L; Ehnholm C; Taskinen M R
Serum complement and familial combined hyperlipidemia.
Atherosclerosis 1997;129(2):271-7.
1997: Tilly-Kiesi M; Kahri J; Pyörälä T; Puolakka J; Luotola H; Lappi M; Lahdenperä S; Taskinen M R
Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
Atherosclerosis 1997;129(2):249-59.
1997: Eliasson B; Mero N; Taskinen M R; Smith U
The insulin resistance syndrome and postprandial lipid intolerance in smokers.
Atherosclerosis 1997;129(1):79-88.
1997: Syvänne M; Taskinen M R; Nieminen; Manninen V; Kesäniemi Y A; Pasternack A; Nawrocki J W; Haber H; Frick M H
A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT Study. Lopid Coronary Angiography Trial.
Controlled clinical trials 1997;18(1):93-119.
1997: Tilly-Kiesi M; Packard C J; Kahri J; Ehnholm C; Shepherd J; Taskinen M R
In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys107-->0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiency.
Atherosclerosis 1997;128(2):213-22.
1997: Knudsen P; Antikainen M; Uusi-Oukari M; Ehnholm S; Lahdenperä S; Bensadoun A; Funke H; Wiebusch H; Assmann G; Taskinen M R; Ehnholm C
Heterozygous hepatic lipase deficiency, due to two missense mutations R186H and L334F, in the HL gene.
Atherosclerosis 1997;128(2):165-74.
1997: Lehto M; Tuomi T; Mahtani M M; Widén E; Forsblom C; Sarelin L; Gullström M; Isomaa B; Lehtovirta M; Hyrkkö A; Kanninen T; Orho M; Manley S; Turner R C; Brettin T; Kirby A; Thomas J; Duyk G; Lander E; Taskinen M R; Groop L
Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect.
The Journal of clinical investigation 1997;99(4):582-91.
1996: Syvänne M; Castro G; Dengremont C; De Geitere C; Jauhiainen M; Ehnholm C; Michelagnoli S; Franceschini G; Kahri J; Taskinen M R
Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein.
Atherosclerosis 1996;127(2):245-53.
1996: Tilly-Kiesi M; Lappi M; Puolakka J; Luotola H; Pyörälä T; Taskinen M R
Different effects of continuous oestrogen-progestin and transdermal oestrogen with cyclic progestin regimens on low-density lipoprotein subclasses.
European journal of clinical investigation 1996;26(12):1125-33.
1996: Saarto T; Blomqvist C; Ehnholm C; Taskinen M R; Elomaa I
Effects of chemotherapy-induced castration on serum lipids and apoproteins in premenopausal women with node-positive breast cancer.
The Journal of clinical endocrinology and metabolism 1996;81(12):4453-7.
1996: Groop L; Forsblom C; Lehtovirta M; Tuomi T; Karanko S; Nissén M; Ehrnström B O; Forsén B; Isomaa B; Snickars B; Taskinen M R
Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects.
Diabetes 1996;45(11):1585-93.
1996: Taskinen M R; Puolakka J; Pyörälä T; Luotola H; Bjäörn M; Kääriänen J; Lahdenperä S; Ehnholm C
Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(10):1215-21.
1996: Eliasson B; Taskinen M R; Smith U
Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance.
Circulation 1996;94(5):878-81.
1996: Malmström R; Taskinen M R; Karonen S L; Yki-Järvinen H
Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM.
Diabetologia 1996;39(8):993-6.
1996: Antikainen M; Suurinkeroinen L; Jauhiainen M; Ehnholm C; Taskinen M R
Development and evaluation of an ELISA method for the determination of lipoprotein lipase mass concentration--comparison with a commercial, one-step enzyme immunoassay.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1996;34(7):547-53.
1996: Tilly-Kiesi M; Knudsen P; Groop L; Taskinen M R
Hyperinsulinemia and insulin resistance are associated with multiple abnormalities of lipoprotein subclasses in glucose-tolerant relatives of NIDDM patients. Botnia Study Group.
Journal of lipid research 1996;37(7):1569-78.
1996: Taskinen M R
Criteria for metabolic control and intervention in diabetes.
Diabetes 1996;45 Suppl 3():S120-2.
1996: Groop P H; Elliott T; Ekstrand A; Franssila-Kallunki A; Friedman R; Viberti G C; Taskinen M R
Multiple lipoprotein abnormalities in type I diabetic patients with renal disease.
Diabetes 1996;45(7):974-9.
1996: Antikainen M; Tenkanen H; Taskinen M R; Ehnholm C
Mutations affecting human lipoprotein lipase gene.
Zeitschrift für Gastroenterologie 1996;34 Suppl 3():59-61.
1996: Lahdenperä S; Puolakka J; Pyörälä T; Luotola H; Taskinen M R
Effects of postmenopausal estrogen/progestin replacement therapy on LDL particles; comparison of transdermal and oral treatment regimens.
Atherosclerosis 1996;122(2):153-62.
1996: Lahdenperä S; Syvänne M; Kahri J; Taskinen M R
Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides.
Diabetologia 1996;39(4):453-61.
1996: Knudsen P; Antikainen M; Ehnholm S; Uusi-Oukari M; Tenkanen H; Lahdenperä S; Kahri J; Tilly-Kiesi M; Bensadoun A; Taskinen M R; Ehnholm C
A compound heterozygote for hepatic lipase gene mutations Leu334-->Phe and Thr383-->Met: correlation between hepatic lipase activity and phenotypic expression.
Journal of lipid research 1996;37(4):825-34.
1996: Syvänne M; Antikainen M; Ehnholm S; Tenkanen H; Lahdenperä S; Ehnholm C; Taskinen M R
Heterozygosity for Asn291-->Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia.
Journal of lipid research 1996;37(4):727-38.
1996: Saarto T; Blomqvist C; Ehnholm C; Taskinen M R; Elomaa I
Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):429-33.
1995: Kahri J; Sane T; van Tol A; Taskinen M R
Effect of gemfibrozil on the regulation of HDL subfractions in hypertriglyceridaemic patients.
Journal of internal medicine 1995;238(5):429-36.
1995: Tilly-Kiesi M; Zhang Q; Ehnholm S; Kahri J; Lahdenperä S; Ehnholm C; Taskinen M R
ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(9):1294-306.
1995: Syvänne M; Kahri J; Virtanen K S; Taskinen M R
HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus.
Circulation 1995;92(3):364-70.
1995: Sane T; Knudsen P; Vuorinen-Markkola H; Yki-Järvinen H; Taskinen M R
Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia.
Metabolism: clinical and experimental 1995;44(5):589-96.
1995: Axelsen M; Eliasson B; Joheim E; Lenner R A; Taskinen M R; Smith U
Lipid intolerance in smokers.
Journal of internal medicine 1995;237(5):449-55.
1995: Syvänne M; Ahola M; Lahdenperä S; Kahri J; Kuusi T; Virtanen K S; Taskinen M R
High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease.
Journal of lipid research 1995;36(3):573-82.
1995: Forsblom C M; Eriksson J G; Ekstrand A V; Teppo A M; Taskinen M R; Groop L C
Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM.
Diabetologia 1995;38(3):363-9.
1995: Knudsen P; Eriksson J; Lahdenperä S; Kahri J; Groop L; Taskinen M R
Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group.
Diabetologia 1995;38(3):344-50.
1995: Lahdenperä S; Sane T; Vuorinen-Markkola H; Knudsen P; Taskinen M R
LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes.
Atherosclerosis 1995;113(2):227-36.
1994: Kahri J; Syvänne M; Taskinen M R
Plasma cholesteryl ester transfer protein activity in non-insulin-dependent diabetic patients with and without coronary artery disease.
Metabolism: clinical and experimental 1994;43(12):1498-502.
1994: Eliasson B; Attvall S; Taskinen M R; Smith U
The insulin resistance syndrome in smokers is related to smoking habits.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(12):1946-50.
1994: Groop P H; Viberti G C; Elliott T G; Friedman R; Mackie A; Ehnholm C; Jauhiainen M; Taskinen M R
Lipoprotein(a) in type 1 diabetic patients with renal disease.
Diabetic medicine : a journal of the British Diabetic Association 1994;11(10):961-7.
1994: Puhakainen I; Taskinen M R; Yki-Järvinen H
Comparison of acute daytime and nocturnal insulinization on diurnal glucose homeostasis in NIDDM.
Diabetes care 1994;17(8):805-9.
1994: Lahdenperä S; Groop P H; Tilly-Kiesi M; Kuusi T; Elliott T G; Viberti G C; Taskinen M R
LDL subclasses in IDDM patients: relation to diabetic nephropathy.
Diabetologia 1994;37(7):681-8.
1994: Kahri J; Groop P H; Elliott T; Viberti G; Taskinen M R
Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-I-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathy.
Diabetes care 1994;17(5):412-9.
1994: Antikainen M; Holmberg C; Taskinen M R
Short-term effects of renal transplantation on plasma lipids and lipoprotein lipase in children with congenital nephrosis.
Clinical nephrology 1994;41(5):284-9.
1994: Saloranta C; Groop L; Ekstrand A; Franssila-Kallunki A; Taskinen M R
The effect of an antilipolytic agent (acipimox) on the insulin resistance of lipid and glucose metabolism in hypertriglyceridaemic patients.
Acta diabetologica 1994;31(1):6-13.
1994: Tenkanen H; Taskinen M R; Antikainen M; Ulmanen I; Kontula K; Ehnholm C
A novel amino acid substitution (His183-->Gln) in exon 5 of the lipoprotein lipase gene results in loss of catalytic activity: phenotypic expression of the mutant gene in a heterozygous state.
Journal of lipid research 1994;35(2):220-8.
1994: Antikainen M; Sariola H; Rapola J; Taskinen M R; Holthöfer H; Holmberg C
Pathology of renal arteries of dyslipidemic children with congenital nephrosis.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1994;102(2):129-34.
1994: Syvänne M; Rosseneu M; Labeur C; Hilden H; Taskinen M R
Enrichment with apolipoprotein E characterizes postprandial TG-rich lipoproteins in patients with non-insulin-dependent diabetes mellitus and coronary artery disease: a preliminary report.
Atherosclerosis 1994;105(1):25-34.
1994: Syvänne M; Hilden H; Taskinen M R
Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease.
Journal of lipid research 1994;35(1):15-26.
1993: Saloranta C; Groop L; Ekstrand A; Franssila-Kallunki A; Eriksson J; Taskinen M R
Different acute and chronic effects of acipimox treatment on glucose and lipid metabolism in patients with type 2 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 1993;10(10):950-7.
1993: Saloranta C; Taskinen M R; Widen E; Härkönen M; Melander A; Groop L
Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM.
Diabetes 1993;42(11):1559-66.
1993: Sane T; Taskinen M R
Does familial hypertriglyceridemia predispose to NIDDM?
Diabetes care 1993;16(11):1494-501.
1993: Kahri J; Groop P H; Viberti G; Elliott T; Taskinen M R
Regulation of apolipoprotein A-I-containing lipoproteins in IDDM.
Diabetes 1993;42(9):1281-8.
1993: Kahri J; Vuorinen-Markkola H; Tilly-Kiesi M; Lahdenperä S; Taskinen M R
Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity.
Atherosclerosis 1993;102(1):79-89.
1993: Välimäki M; Kahri J; Laitinen K; Lahdenperä S; Kuusi T; Ehnholm C; Jauhiainen M; Bard J M; Fruchart J C; Taskinen M R
High density lipoprotein subfractions, apolipoprotein A-I containing lipoproteins, lipoprotein (a), and cholesterol ester transfer protein activity in alcoholic women before and after ethanol withdrawal.
European journal of clinical investigation 1993;23(7):406-17.
1993: Antikainen M; Holmberg C; Olivecrona T; Bengtsson-Olivecrona G; Labeur C; Rosseneu M; Taskinen M R
Changes in biological activity and immunoreactive mass of lipoprotein lipase in congenital nephrosis: relationship to hypertriglyceridaemia.
European journal of clinical investigation 1993;23(6):368-74.
1993: Lahdenperä S; Tilly-Kiesi M; Vuorinen-Markkola H; Kuusi T; Taskinen M R
Effects of gemfibrozil on low-density lipoprotein particle size, density distribution, and composition in patients with type II diabetes.
Diabetes care 1993;16(4):584-92.
1993: Vuorinen-Markkola H; Yki-Järvinen H; Taskinen M R
Lowering of triglycerides by gemfibrozil affects neither the glucoregulatory nor antilipolytic effect of insulin in type 2 (non-insulin-dependent) diabetic patients.
Diabetologia 1993;36(2):161-9.
1993: Koivisto U M; Hämäläinen L; Taskinen M R; Kettunen K; Kontula K
Prevalence of familial hypercholesterolemia among young north Karelian patients with coronary heart disease: a study based on diagnosis by polymerase chain reaction.
Journal of lipid research 1993;34(2):269-77.
1993: Syvänne M; Vuorinen-Markkola H; Hilden H; Taskinen M R
Gemfibrozil reduces postprandial lipemia in non-insulin-dependent diabetes mellitus.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(2):286-95.
1992: Antikainen M; Holmberg C; Taskinen M R
Growth, serum lipoproteins and apoproteins in infants with congenital nephrosis.
Clinical nephrology 1992;38(5):254-63.
1992: Taskinen M R
Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus.
Diabetes 1992;41 Suppl 2():12-7.
1992: Taskinen M R; Kahri J; Koivisto V; Shepherd J; Packard C J
Metabolism of HDL apolipoprotein A-I and A-II in type 1 (insulin-dependent) diabetes mellitus.
Diabetologia 1992;35(4):347-56.
1992: Kolaczynski J W; Taskinen M R; Hilden H; Kiviluoto T; Cantell K; Koivisto V A
Effects of interferon alpha on insulin binding and glucose transport in human adipocytes.
European journal of clinical investigation 1992;22(4):292-9.
1992: Tilly-Kiesi M; Syvänne M; Kuusi T; Lahdenperä S; Taskinen M R
Abnormalities of low density lipoproteins in normolipidemic type II diabetic and nondiabetic patients with coronary artery disease.
Journal of lipid research 1992;33(3):333-42.
1992: Sane T; Helve E; Yki-Järvinen H; Taskinen M R
One-year response to evening insulin therapy in non-insulin-dependent diabetes.
Journal of internal medicine 1992;231(3):253-60.
1992: Nieminen M S; Mattila K J; Aalto-Setälä K; Kuusi T; Kontula K; Kauppinen-Mäkelin R; Ehnholm C; Jauhiainen M; Valle M; Taskinen M R
Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1992;12(1):58-69.
1991: Välimäki M; Laitinen K; Ylikahri R; Ehnholm C; Jauhiainen M; Bard J M; Fruchart J C; Taskinen M R
The effect of moderate alcohol intake on serum apolipoprotein A-I-containing lipoproteins and lipoprotein (a).
Metabolism: clinical and experimental 1991;40(11):1168-72.
1991: Saloranta C; Franssila-Kallunki A; Ekstrand A; Taskinen M R; Groop L
Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus.
Diabetologia 1991;34(6):409-15.
1991: Yki-Järvinen H; Puhakainen I; Saloranta C; Groop L; Taskinen M R
Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources.
The American journal of physiology 1991;260(5 Pt 1):E680-9.
1990: Taskinen M R; Packard C J; Shepherd J
Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.
Diabetes 1990;39(9):1017-27.
1990: Taskinen M R
Mechanisms behind the abnormalities of plasma lipids and lipoproteins in noninsulin-dependent diabetes.
The Journal of diabetic complications 1990;4(2):49-52.
1989: Yki-Järvinen H; Helve E; Sane T; Nurjhan N; Taskinen M R
Insulin inhibition of overnight glucose production and gluconeogenesis from lactate in NIDDM.
The American journal of physiology 1989;256(6 Pt 1):E732-9.
1989: Taskinen M R; Sane T; Helve E; Karonen S L; Nikkilä E A; Yki-Järvinen H
Bedtime insulin for suppression of overnight free-fatty acid, blood glucose, and glucose production in NIDDM.
Diabetes 1989;38(5):580-8.
1989: Kuusi T; Nieminen M S; Ehnholm C; Yki-Järvinen H; Valle M; Nikkilä E A; Taskinen M R
Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients.
Arteriosclerosis (Dallas, Tex.) 1989;9(2):237-41.
1988: Aalto-Setälä K; Tikkanen M J; Taskinen M R; Nieminen M; Holmberg P; Kontula K
XbaI and c/g polymorphisms of the apolipoprotein B gene locus are associated with serum cholesterol and LDL-cholesterol levels in Finland.
Atherosclerosis 1988;74(1-2):47-54.
1988: Välimäki M; Taskinen M R; Ylikahri R; Roine R; Kuusi T; Nikkilä E A
Comparison of the effects of two different doses of alcohol on serum lipoproteins, HDL-subfractions and apolipoproteins A-I and A-II: a controlled study.
European journal of clinical investigation 1988;18(5):472-80.
1988: Sammalkorpi K; Valtonen V; Kerttula Y; Nikkilä E; Taskinen M R
Changes in serum lipoprotein pattern induced by acute infections.
Metabolism: clinical and experimental 1988;37(9):859-65.
1988: Yki-Järvinen H; Taskinen M R
Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia.
Diabetes 1988;37(9):1271-8.
1988: Taskinen M R; Kuusi T; Yki-Järvinen H; Nikkilä E A
Short-term effects of prednisone on serum lipids and high density lipoprotein subfractions in normolipidemic healthy men.
The Journal of clinical endocrinology and metabolism 1988;67(2):291-9.
1988: Kuusi T; Taskinen M R; Solakivi T; Kauppinen-Mäkelin R
Role of apolipoproteins E and C in type V hyperlipoproteinemia.
Journal of lipid research 1988;29(3):293-8.
1988: Taskinen M R; Kuusi T; Helve E; Nikkilä E A; Yki-Järvinen H
Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes.
Arteriosclerosis (Dallas, Tex.) 1988;8(2):168-77.
1988: Sorva R; Kuusi T; Dunkel L; Taskinen M R
Effects of endogenous sex steroids on serum lipoproteins and postheparin plasma lipolytic enzymes.
The Journal of clinical endocrinology and metabolism 1988;66(2):408-13.
1988: Tilvis R S; Taskinen M R; Miettinen T A
Effect of insulin treatment on fatty acids of plasma and erythrocyte membrane lipids in type 2 diabetes.
Clinica chimica acta; international journal of clinical chemistry 1988;171(2-3):293-303.
1988: Taskinen M R; Nikkilä E A
Effects of acipimox on serum lipids, lipoproteins and lipolytic enzymes in hypertriglyceridemia.
Atherosclerosis 1988;69(2-3):249-55.
1988: Yki-Järvinen H; Koivisto V A; Ylikahri R; Taskinen M R
Acute effects of ethanol and acetate on glucose kinetics in normal subjects.
The American journal of physiology 1988;254(2 Pt 1):E175-80.
1988: Kuusi T; Taskinen M R; Nikkilä E A
Lipoproteins, lipolytic enzymes, and hormonal status in hypothyroid women at different levels of substitution.
The Journal of clinical endocrinology and metabolism 1988;66(1):51-6.
1988: Taskinen M R
Lipoprotein lipase.
Hormone and metabolic research. Supplement series 1988;19():53-7.
1984: Yki-Järvinen H; Taskinen M R; Kiviluoto T; Hilden H; Helve E; Koivisto V A; Nikkilä E A
Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.
The Journal of clinical endocrinology and metabolism 1984;59(6):1183-92.
1980: Taskinen M R; Nikkilä E A; Huttunen J K; Hilden H
A micromethod for assay of lipoprotein lipase activity in needle biopsy samples of human adipose tissue and skeletal muscle.
Clinica chimica acta; international journal of clinical chemistry 1980;104(1):107-17.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Marja-Riitta Taskinen

Research Profile (preview)

Disorders

Chemicals & Drugs

Geographic Areas

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Marja-Riitta Taskinen (preview)

All Publications